The Vertebral Osteoporosis (2)
today we talk a little bit of science, according to the post. I will comment on 3 previous treatment approaches for osteoporosis:
1) HRT (hormone replacement therapy) still creates controversy in relation to breast cancer, only take 5% of menopausal women, this treatment should be monitored by the doctor, individualized, tailored to each woman to avoid risks and reviewed annually.
In most menopausal women is a safe treatment but only where evidence indicated a potential benefit.
. Women with a family history of breast cancer suffer more risk when using this treatment.
. Young women with hysterectomy are no risk of cancer.
2) Currently studies are underway to combat osteoporosis in the project ATPBone (combat osteoporosis by blocks of nucleotides: purinergic signaling in bone formation and homeostasis) financed with European funds, have shown that physical activity and other incentives to bone induce the emission of a compound called ATP that regulates bone regeneration.
3) An example of innovation in biotechnology for human health is the Denosumab (marketed under the name Prolia) is a treatment-finally available in Spain and to treat postmenopausal osteoporosis in women at high risk of osteoporotic fracture; reduces the risk of vertebral fracture, nonvertebral and hip fractures.
This drug acts on an essential regulator of osteoclasts (cells that break down bone) and consists of a subcutaneous injection every 6 months.
